X4 Pharmaceuticals, Inc: Form 8-K, filed Aug 9, 2024
Filed with the SEC on Aug 9, 2024 and accepted by EDGAR at Aug 9, 2024, 16:28 ET.
Items reported
- Item 7.01 Regulation FD disclosure
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001628280-24-036495. Last ingested by Listed: Oct 29, 2026, 10:01 ET. Listed shows no prices and gives no investment advice.